Poor prognosis in nasopharyngeal cancer patients with low glucose-6-phosphate-dehydrogenase activity

Japanese Journal of Cancer Research

Volumn 92, Issue 5, 2001, Pages 576-581

  Cheng, Ann Joy ^a   Chiu, Daniel Tsun Yee ^a   See, Lai Chu ^a   Liao, Chun Ta ^b   Chen, I How ^b   Chang, Joseph Tung Chieh ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Epstein barr virus; G6PD; Nasopharyngeal cancer; Oxidative defense

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ADULT; AGED; AGING; ARTICLE; CANCER; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CELL DAMAGE; CELL PROTECTION; CHINA; CONTROLLED STUDY; CORRELATION FUNCTION; DEGENERATIVE DISEASE; ENDEMIC DISEASE; ENZYME ACTIVITY; EPIDEMIC; ERYTHROCYTE; ETHNIC GROUP; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; HUMAN TISSUE; INBORN ERROR OF METABOLISM; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CANCER; OXIDATION; PRIORITY JOURNAL; PROGNOSIS; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; ERYTHROCYTE COUNT; ERYTHROCYTES; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; TAIWAN;

EID: 0034981829     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2001.tb01132.x     Document Type: Article

References (27)

1. Biology and treatment of nasopharyngeal cancer
2. Nasopharyngeal cancer: Epidemiology, staging, and treatment
3. Nasopharyngeal carcinoma: The Epstein-Barr virus association
4. Nasopharyngeal carcinoma: Genetic changes, Epstein-Barr virus infection, or both
5. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region
6. Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma
7. A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma
8. Glucose-6-phosphate dehydrogenase
9. Free radical-lipid interactions and their pathological consequences
10. Oxidants, antioxidants and the degenerative disease of aging
11. Oxidative mechanisms in carcinogenesis
12. Glucose-6-phosphate dehydrogenase variants and their frequency in Guangdong
13. Favism and its detection
14. Early stage nasopharyngeal carcinoma: Radiotherapy dose and time factors in tumor control
15. The role of brachytherapy in early-stage nasopharyngeal carcinoma
16. Free radicals in viral pathogenesis: Molecular mechanisms involving superoxide and NO
17. Oxidative stress during viral infection: A review
18. Intracellular thiols regulate activation of nuclear factor B and transcription of human immunodeficiency virus
19. Increased virulence of human enterovirus (coxsackievirus B3) in selenium-deficient mice
20. Biologic basis for radiation oncology
21. Severe glucose-6-phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections: Description of a new molecular variant (G6PD Barcelona)
22. Nitric oxide as a secretory production of mammalian cells
23. Impaired production of nitric oxide, superoxide, and hydrogen peroxide in glucose 6-phosphate-dehydrogenase-deficient granulocytes
24. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099
25. Acute toxicities and feasibility of altered fractionated radiotherapy in nasopharyngeal carcinoma